RNA modifications and cancer
RNA modifications and cancer is a research topic within Molecular Biology. Science Explorer counts 89k research works in it since 1950. 9.8% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the diverse landscape of RNA methylation, with a focus on m6A modification, its impact on gene expression, ribosome biogenesis, and its role in cancer progression. The research covers various aspects such as m6A-seq, tRNA fragments, YTHDF proteins, and the involvement of methyltransferases in mRNA modification.
- m6A-seq
- RNA methylation
- mRNA modification
- epitranscriptome
- ribosome biogenesis
- tRNA fragments
- YTHDF proteins
- cancer progression
- methyltransferases
- gene expression regulation
- Research works
- 89k fractional, since 1950
- In the world top 10%
- 8.7k per year above
- Top-10% rate
- 9.8% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +15% the tick is no change
- Largest producer
China
55% of the 10 largest, 2022-now
Which countries lead RNA modifications and cancer research?
By volume, China and the United States publish the most (9.5k and 4.1k works in 2022-now).
By volume, 2022-now
- 1
China 9.5k works
- 2
United States 4.1k works
- 3
Germany 638 works
- 4
Japan 599 works
- 5
India 588 works
- 6
United Kingdom 484 works
- 7
France 412 works
- 8
Italy 357 works
- 9
South Korea 323 works
- 10
Canada 323 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead RNA modifications and cancer research?
By volume in 2022-now, Sun Yat-sen University publishes the most RNA modifications and cancer research, followed by Shanghai Jiao Tong University and Nanjing Medical University.
By volume, 2022-now
- 1
Sun Yat-sen University
China 321 works
- 2
Shanghai Jiao Tong University
China 239 works
- 3
Nanjing Medical University
China 236 works
- 4
Central South University
China 223 works
- 5
Zhejiang University
China 206 works
- 6
Chinese Academy of Sciences
China 205 works
- 7
Harvard University
United States 175 works
- 8
Wuhan University
China 168 works
- 9
Fudan University
China 158 works
- 10
Sichuan University
China 157 works
Who are the leading researchers in RNA modifications and cancer?
The most-cited researchers publishing on RNA modifications and cancer include Eric S. Lander, Zhong Lin Wang and Rob Knight.
- 1
Eric S. Lander
United States 524k citations
- 2
Zhong Lin Wang
United States 491k citations
- 3
Rob Knight
United States 468k citations
- 4
George Davey Smith
United Kingdom 435k citations
- 5
Ali H. Mokdad
United States 429k citations
- 6
Richard M. Durbin
United Kingdom 410k citations
- 7
Mark J. Daly
United States 403k citations
- 8
Stacey L. Gabriel
United States 402k citations
- 9
Peer Bork
Germany 396k citations
- 10
Robert John Tibshirani
United States 396k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is RNA modifications and cancer research done?
The largest centres of RNA modifications and cancer research in 2022-now are Beijing (China), Shanghai (China), Guangzhou (China) and Wuhan (China). Among places with at least 20 works in it, it is an unusually large share of all research in Chevy Chase and Nantong.
Largest cities, 2022-now
Where it is the local speciality
- Chevy ChaseUS · 38.4 works22×
- NantongCN · 90.9 works9.8×
Location quotient: how much more of its research is in RNA modifications and cancer than the world average.
Where is the best place to study RNA modifications and cancer?
Among universities, judged by research, Sun Yat-sen University, Rockefeller University and Harvard University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in RNA modifications and cancer, country by countryIs RNA modifications and cancer research growing?
Output in 2022-2025 was 15% higher than in 2018-2021, peaking in 2022. The fastest-growing topics are RNA modifications and cancer.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is RNA modifications and cancer as a percentage of every work published that year, 0.088% in 2024.
Fractional works of RNA modifications and cancer over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about RNA modifications and cancer. Posts are plain text and can be reported.